New advances provide new hope for prosthetics, including an accurate sense of touch and robotic limbs developed at a fraction of the cost.
Before testing your own genome, it helps to realize it can raise more questions than it answers.
A $199 service from health company 23andMe gives individuals data from ancestry to risks of carrying a genetic condition.
Personalized medicine is more costly than traditional treatment, which worries insurers. But these drugs can improve outcomes for patients.
About 1 in 5 Medicare dollars is spent on this disease that affects over 5 million Americans. Yet not enough is being done to find a cure.
Elton John told CNBC that he could petition the queen to force Commonwealth countries to revoke anti-gay legislation.
Bone replacements, human tissue and prosthetics are being created by 3-D bioprinters. The science will soon be used to customize drugs.
Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.
As baby boomers age, UPS, FedEx and DHL expect health-care logistics to become a more important part of their future.
China's much-hyped market for vitamins and supplements is facing a steep challenge from traditional remedies from ginseng to deer antler.
Teen creates cheaper way to test for Ebola
Contact lens manufacturers appeal Utah decision that bans minimum prices for contact lenses.
Nike is releasing a new, easy-entry footwear system this month.
Bad news has been a boon for Malaysia's rubber glove makers, with the ringgit's drop and South Korea's MERS outbreak likely to provide a twin boost.
Mark Cuban said innovative tech in the pharmaceutical sector is going to be a game changer not only for health care, but for humanity.
Pavle Sabic, director of Credit Market Development at S&P Capital IQ, discusses the healthcare sector in terms of investing.
CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.
This list represents the largest capital commitments raised by private U.S. companies actively listed on equity crowdfunding platforms.
Anmol Madan, Ginger.io CEO, discusses how his company's technology helps track a patient's well-being.
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.